​

Funding Round

Series A - Altheos

Series A - Altheos

Investment Firm

Overview

Altheos was a biopharmaceutical company focused on the development of small molecule drugs.

Announced Date

Apr 05, 2010

Funding Type

Series A

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Bay City Capital

Bay City Capital

Bay City Capital is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

5

Investor Name
Participant InvestorAtheneos Ventures
Participant InvestorNovo Holdings
Participant InvestorLife Science Angels
Participant InvestorBay City Capital
Participant InvestorCanaan Partners

Round Details and Background

Altheos raised $20000000 on 2010-04-05 in Series A

Altheos was a biopharmaceutical company focused on the development of small molecule drugs.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 09, 2012
Series A - Altheos
3-12.5M
Apr 05, 2010
Series A - Altheos
5-20.0M

Recent Activity

There is no recent news or activity for this profile.